<p>The ADA updated its treatment guidelines for patients with diabetic kidney disease based on the results of the Credence trial.</p>

The ADA updated its treatment guidelines for patients with diabetic kidney disease based on the results of the Credence trial.

Univadis Practice Changers: Canagliflozin for diabetic kidney disease

If you're a family medicine physician or other primary care clinician, you know how hard it is to keep up with the latest research. The Univadis Practice Changers podcast provides expert analysis on the most essential new evidence in medicine. In 5 minutes or less, you'll hear experts go beyond the details of the latest study to the real-world clinical applications. Univadis Practice Changers is a quick look at essential evidence changing your daily practice.

Share Univadis Practice Changers: Canagliflozin for diabetic kidney disease

Sign up to save your podcasts

Univadis Practice Changers: Canagliflozin for diabetic kidney disease

Univadis Practice Changers: Canagliflozin for diabetic kidney disease